Mardi Gomberg-Maitland, MD
George Washington University · University of Chicago
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mardi Gomberg-Maitland, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:41 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04882774 · Telemonitoring to Treat Group 2 Pulmonary HypertensionMardi Gomberg -Maitland MD, MSc · withdrawn · Pulmonary Hypertension Due to Left Heart Disease · principal investigator
- Ph3NCT03043651 · Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEFUnited Therapeutics · terminated · Pulmonary Hypertension Associated With HFpEF · principal investigator
- Ph3NCT03037580 · Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection FractionUnited Therapeutics · terminated · Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction · principal investigator
- Ph1NCT01757808 · A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial HypertensionUniversity of Chicago · completed · Pulmonary Arterial Hypertension · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.